Abstract
Troglitazone is the first of a new family of antihyperglycemic drugs. We review its use in clinical practice.
MeSH terms
-
Chromans / therapeutic use*
-
Diabetes Mellitus, Type 2 / drug therapy*
-
Diabetes Mellitus, Type 2 / metabolism
-
Gluconeogenesis / drug effects
-
Humans
-
Hypoglycemic Agents / therapeutic use*
-
Insulin Resistance
-
Thiazoles / therapeutic use*
-
Thiazolidinediones*
-
Troglitazone
Substances
-
Chromans
-
Hypoglycemic Agents
-
Thiazoles
-
Thiazolidinediones
-
Troglitazone